Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-09-09 Option Award | 2022-09-13 4:07 pm | N/A N/A | NAVIDEA BIOPHARMACEUTICALS INC. | NAVB | Rosol Michael Stanley Chief Medical Officer | 41,150 | $0 | 67,045 (Direct) | View |
| 2021-12-27 Option Award(A) | 2022-03-08 4:01 pm | N/A 2031-12-27 | NAVIDEA BIOPHARMACEUTICALS INC. | NAVB | Rosol Michael Stanley Chief Medical Officer | 100,000 | $0.001 | 100,000 (Direct) | View |
| 2022-01-14 Option Award | 2022-01-18 09:28 am | N/A N/A | NAVIDEA BIOPHARMACEUTICALS INC. | NAVB | Rosol Michael Stanley Chief Medical Officer | 7,728 | $0 | 21,391 (Direct) | View |
| 2021-12-27 Option Award | 2021-12-29 4:56 pm | N/A 2031-12-27 | NAVIDEA BIOPHARMACEUTICALS INC. | NAVB | Rosol Michael Stanley Chief Medical Officer | 100,000 | $0.001 | 100,000 (Direct) | View |
| 2021-02-15 Option Award | 2021-02-17 4:11 pm | N/A 2031-02-15 | NAVIDEA BIOPHARMACEUTICALS INC. | NAVB | Rosol Michael Stanley Chief Medical Officer | 25,000 | $0.001 | 31,816 (Direct) | View |
| 2020-06-02 Option Award | 2020-06-04 4:18 pm | N/A N/A | NAVIDEA BIOPHARMACEUTICALS INC. | NAVB | Rosol Michael Stanley Chief Medical Officer | 6,847 | $2.62 | 13,097 (Direct) | View |
| 2020-02-06 Option Award | 2020-02-07 4:17 pm | N/A 2030-02-06 | NAVIDEA BIOPHARMACEUTICALS INC. | NAVB | Rosol Michael Stanley Chief Medical Officer | 25,000 | $0.001 | 31,250 (Direct) | View |